Literature DB >> 23073322

Follicular peripheral T-cell lymphoma expands the spectrum of classical Hodgkin lymphoma mimics.

Julien Moroch1, Christiane Copie-Bergman, Laurence de Leval, Anne Plonquet, Nadine Martin-Garcia, Marie-Hélène Delfau-Larue, Valérie Molinier-Frenkel, Karim Belhadj, Corinne Haioun, Josée Audouin, Steven H Swerdlow, Teresa Marafioti, Philippe Gaulard.   

Abstract

Epstein-Barr virus (EBV)-infected B cells with Reed-Sternberg-like cell (RS) features may occur in peripheral T-cell lymphomas (PTCLs), especially in angioimmunoblastic T-cell lymphoma. Here, we report 5 patients presenting with lymphadenopathy whose first biopsies demonstrated nodular lymphoid proliferations containing scattered CD30+, CD15+, EBV+ Hodgkin and Reed-Sternberg-like cells, which led to an initial diagnosis of lymphocyte-rich classical Hodgkin lymphoma. However, the uncommon clinical features and/or the occurrence of relapse as PTCL prompted review of the biopsies with expanded immunohistologic and molecular studies and revision of the diagnoses to follicular variant of PTCL (F-PTCL). All cases had atypical small to medium-sized CD3+ T cells that expressed CD10 (4/5) and the follicular helper T-cell (TFH) antigens BCL6, PD1, CXCL13, and ICOS. All demonstrated clonal T cells with a similar pattern in multiple samples from 4 patients. In 2 cases, flow cytometry demonstrated circulating lymphocytes with an abnormal sCD3+, CD4+, ICOS+ immunophenotype. Two patients had a skin rash at presentation, and 1 had B symptoms. Two of the 4 patients treated with polychemotherapy are alive at 3 and 6 years after first diagnosis. These cases highlight how some F-PTCLs may closely mimic lymphocyte-rich classical Hodgkin lymphoma requiring careful assessment of the T cells before rendering the latter diagnosis. The functional properties of TFH cells might lead to the presence of EBV-positive B blasts with RS-like features in TFH-derived PTCL such as angioimmunoblastic T-cell lymphoma and F-PTCL.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23073322     DOI: 10.1097/PAS.0b013e318268d9ff

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  22 in total

Review 1.  Diagnosis of Hodgkin lymphoma in the modern era.

Authors:  Hao-Wei Wang; Jayalakshmi P Balakrishna; Stefania Pittaluga; Elaine S Jaffe
Journal:  Br J Haematol       Date:  2018-11-08       Impact factor: 6.998

Review 2.  [Update on nodular lymphocyte predominant Hodgkin's lymphoma and related lesions].

Authors:  S Hartmann; M-L Hansmann
Journal:  Pathologe       Date:  2017-02       Impact factor: 1.011

Review 3.  [Nodular lymphocyte-predominant Hodgkin's lymphoma and differential diagnoses].

Authors:  S Hartmann; S Cogliatti; M-L Hansmann
Journal:  Pathologe       Date:  2013-05       Impact factor: 1.011

Review 4.  Recent Progress in the Understanding of Angioimmunoblastic T-cell Lymphoma.

Authors:  Manabu Fujisawa; Shigeru Chiba; Mamiko Sakata-Yanagimoto
Journal:  J Clin Exp Hematop       Date:  2017

5.  Clinicopathological features of adult T-cell leukemia/lymphoma with HTLV-1-infected Hodgkin and Reed-Sternberg-like cells.

Authors:  Kennosuke Karube; Mitsuyoshi Takatori; Shugo Sakihama; Yuma Tsuruta; Takashi Miyagi; Kazuho Morichika; Sakiko Kitamura; Norihiro Nakada; Masaki Hayashi; Shohei Tomori; Iwao Nakazato; Kazuiku Ohshiro; Naoki Imaizumi; Yara Yukie Kikuti; Naoya Nakamura; Satoko Morishima; Hiroaki Masuzaki; Takuya Fukushima
Journal:  Blood Adv       Date:  2021-01-12

Review 6.  The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

Authors:  Steven H Swerdlow; Elias Campo; Stefano A Pileri; Nancy Lee Harris; Harald Stein; Reiner Siebert; Ranjana Advani; Michele Ghielmini; Gilles A Salles; Andrew D Zelenetz; Elaine S Jaffe
Journal:  Blood       Date:  2016-03-15       Impact factor: 22.113

7.  Global transcriptome analysis and enhancer landscape of human primary T follicular helper and T effector lymphocytes.

Authors:  Jason S Weinstein; Kimberly Lezon-Geyda; Yelena Maksimova; Samuel Craft; Yaoping Zhang; Mack Su; Vincent P Schulz; Joseph Craft; Patrick G Gallagher
Journal:  Blood       Date:  2014-10-20       Impact factor: 22.113

Review 8.  Lymphoma classification update: T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms.

Authors:  Manli Jiang; N Nora Bennani; Andrew L Feldman
Journal:  Expert Rev Hematol       Date:  2017-01-29       Impact factor: 2.929

Review 9.  Pathobiology of T-cell and NK-cell lymphomas.

Authors:  Ewa B Bajor-Dattilo; Stefania Pittaluga; Elaine S Jaffe
Journal:  Best Pract Res Clin Haematol       Date:  2013-05-23       Impact factor: 3.020

Review 10.  Clinical Impact of the 2016 Update to the WHO Lymphoma Classification.

Authors:  Ryan C Lynch; Dita Gratzinger; Ranjana H Advani
Journal:  Curr Treat Options Oncol       Date:  2017-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.